Akebia Therapeutics Executives Make Major Trades Amid Market Volatility

Akebia Therapeutics, Inc. recently announced various transactions involving its senior officers and directors. Burke Steven Keith, the company's Senior Vice President and Chief Medical Officer, sold 21,582 shares at $1.39 per share on February 2, 2026. Additionally, Keith sold 25,375 shares and 20,701 shares at the same price on the same day. In contrast, John P. Butler, the Director, CEO, and President, purchased 175,250 shares at $1.41 per share on February 2, 2026. Butler also sold 46,660 shares, 83,689 shares, 96,065 shares, and 114,891 shares at $1.39 per share on the same day. Other transactions involved Chief Commercial Officer Nicholas Grund, who sold 53,585 shares and 31,244 shares at $1.39 per share on February 2, 2026. SVP, Chief Accounting Officer Richard C. Malabre sold 36,142 shares and 13,382 shares at the same price on the same day. Erik Ostrowski, the SVP, CFO, CBO, and Treasurer, sold 34,951 shares at $1.39 per share on February 2, 2026. Finally, Carolyn M. Rucci, the SVP, Chief Legal Officer, sold 16,846 shares and 25,382 shares and 27,544 shares at $1.39 per share on the same day.